Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock.

Interleukin-6 (IL-6) is produced within multiple tissues and can be readily detected in the circulation in resuscitated hemorrhagic shock (HS). Instillation of IL-6 into lungs of normal rats induces polymorphonuclear neutrophilic granulocyte (PMN) infiltration and lung damage, while infusion of IL-6 into the systemic circulation of rats during resuscitation from HS reduces PMN recruitment and lung injury. The current study was designed to determine whether or not IL-6 makes an essential contribution to postresuscitation inflammation and which of the two effects of IL-6, its local proinflammatory effect or its systemic anti-inflammatory effect, is dominant in HS. Wild-type and IL-6-deficient mice were subjected to HS followed by resuscitation and death 4 h later. IL-6-deficient mice subjected to HS did not demonstrate any features of postresuscitation inflammation observed in wild-type mice, including increased PMN infiltration into the lungs, increased alveolar cross-sectional surface area, increased PMN infiltration into the liver, increased liver necrosis, increased signal transducer and activator of transcription 3 activation, and increased nuclear factor-kappaB activity. These findings indicate that IL-6 is an essential component of the postresuscitation inflammatory cascade in HS and that the local proinflammatory effects of IL-6 on PMN infiltration and organ damage in HS dominate over the anti-inflammatory effects of systemic IL-6.

[1]  D. Tweardy,et al.  Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. , 2000, Shock.

[2]  G. Ciliberto,et al.  IL‐6 knock‐out mice exhibit resistance to splanchnic artery occlusion shock , 1999, Journal of leukocyte biology.

[3]  P. Patterson,et al.  Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury , 1999, Stem cells.

[4]  Stéphanie Portet,et al.  Quantitative analysis of cytokeratin network topology in the MCF7 cell line. , 1999, Cytometry.

[5]  H. Noda,et al.  Increased Serum Interleukin-8: Correlation with Poor Prognosis in Patients with Postoperative Multiple Organ Failure , 1998, World Journal of Surgery.

[6]  Simon C Watkins,et al.  Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[7]  Kristine L. Danowski,et al.  IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections. , 1998, Journal of immunology.

[8]  E. Moore,et al.  Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. , 1998, The Journal of surgical research.

[9]  A. Peitzman,et al.  Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock , 1998, The Journal of experimental medicine.

[10]  G. Kollias,et al.  Interleukin 6 Is Required for the Development of Collagen-induced Arthritis , 1998, The Journal of experimental medicine.

[11]  P. Clavien,et al.  Interleukin‐6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent , 1997, Hepatology.

[12]  Simon C Watkins,et al.  Hemorrhagic shock induces G-CSF expression in bronchial epithelium. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[13]  G. Ciliberto,et al.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.

[14]  N. Ida,et al.  Injection time of interleukin-6 determines fatal outcome in experimental endotoxin shock. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  S. Dalrymple,et al.  Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection , 1996, Infection and immunity.

[16]  B. Barton,et al.  Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model , 1996, Infection and immunity.

[17]  T. Billiar,et al.  Hepatic inducible nitric oxide synthase: regulation and function. , 1995, Biochemical Society transactions.

[18]  H. Tilg,et al.  Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy. , 1995, Cytokine.

[19]  S. Dalrymple,et al.  Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia , 1995, Infection and immunity.

[20]  M. Monden,et al.  Changes in serum granulocyte colony-stimulating factor (G-CSF) and interleukin 6 (IL-6) after surgical intervention. , 1995, Research communications in molecular pathology and pharmacology.

[21]  T. Maniatis,et al.  NF-κB: A lesson in family values , 1995, Cell.

[22]  G. Fantuzzi,et al.  Defective inflammatory response in interleukin 6-deficient mice , 1994, The Journal of experimental medicine.

[23]  I. Campbell,et al.  Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. , 1994, The American journal of pathology.

[24]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[25]  G. Ciliberto,et al.  Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.

[26]  B. Barton,et al.  Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model , 1993, Infection and immunity.

[27]  B. Cochran,et al.  The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter. , 1990, The EMBO journal.

[28]  J. Vilček,et al.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.

[29]  M. Sozmen,et al.  Quantitation of histochemical staining of salivary gland mucin using image analysis in cats and dogs. , 1999, Veterinary research.

[30]  D. Tweardy,et al.  Rapid and simultaneous activation of Stat3 and production of interleukin 6 in resuscitated hemorrhagic shock , 1999, Archives of Orthopaedic and Trauma Surgery.

[31]  G. Ciliberto,et al.  Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice. , 1998, Cytokine.

[32]  J. Dipersio Colony-stimulating factors: enhancement of effector cell function. , 1990, Cancer surveys.